Emil Salim , Hilkatul Ilmi , Aty Widyawaruyanti , Natsuhisa Oka
{"title":"Design and synthesis of hydroxychloroquine-sugar conjugates as promising antimalarial agents","authors":"Emil Salim , Hilkatul Ilmi , Aty Widyawaruyanti , Natsuhisa Oka","doi":"10.1016/j.bmcl.2025.130289","DOIUrl":null,"url":null,"abstract":"<div><div>Novel hydroxychloroquine (HCQ)-sugar conjugates were evaluated for their antimalarial activity against chloroquine-sensitive (<em>Pf</em>3D7) and multi-resistant (<em>Pf</em>Dd2) strains of <em>Plasmodium falciparum</em>, cytotoxicity, and hydrolytic stability. HCQ-galactose conjugate with a 1,2-orthioester linkage exhibited the highest activity against <em>Pf</em>3D7 (IC<sub>50</sub> value of 0.018 ± 0.001 μg/mL). Per-<em>O</em>-acetyl-β-<span>d</span>-glucopyranosyl-HCQ exhibited the highest activity against <em>Pf</em>Dd2 (IC<sub>50</sub> = 0.20 ± 0.02 μg/mL), while also maintaining comparable activity against <em>Pf</em>3D7. Orthoester-linked conjugates were gradually hydrolyzed in human serum, resulting in HCQ release, which may contribute to their high activity. Glycosidic bond-linked conjugates showed high hydrolytic stability, retaining a certain level of activity, possibly without releasing HCQ. Toxicity assessments using the BHK21 cell line indicated significantly lower cytotoxicity for all HCQ-sugar conjugates compared to HCQ.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"125 ","pages":"Article 130289"},"PeriodicalIF":2.5000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960894X25001982","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Novel hydroxychloroquine (HCQ)-sugar conjugates were evaluated for their antimalarial activity against chloroquine-sensitive (Pf3D7) and multi-resistant (PfDd2) strains of Plasmodium falciparum, cytotoxicity, and hydrolytic stability. HCQ-galactose conjugate with a 1,2-orthioester linkage exhibited the highest activity against Pf3D7 (IC50 value of 0.018 ± 0.001 μg/mL). Per-O-acetyl-β-d-glucopyranosyl-HCQ exhibited the highest activity against PfDd2 (IC50 = 0.20 ± 0.02 μg/mL), while also maintaining comparable activity against Pf3D7. Orthoester-linked conjugates were gradually hydrolyzed in human serum, resulting in HCQ release, which may contribute to their high activity. Glycosidic bond-linked conjugates showed high hydrolytic stability, retaining a certain level of activity, possibly without releasing HCQ. Toxicity assessments using the BHK21 cell line indicated significantly lower cytotoxicity for all HCQ-sugar conjugates compared to HCQ.
期刊介绍:
Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.